KreaMedica


Consulting firm that manages outsourced drug development programs by coordinating CROs/CMOs and external experts. Services span lead candidate selection, nonclinical safety assessment, early clinical trials, regulatory strategy, vendor selection, monitoring for GLP compliance, and specialist scientific support through a consultant engagement platform.

Industries

bioinformatics
biotechnology
consulting

Nr. of Employees

small (1-50)

KreaMedica

Montréal, Quebec, Canada, North America


Products

Consultant engagement platform

Platform to find and engage consultants and external experts for program planning and execution.

Case study package (PDF)

Downloadable package of case studies describing past development programs.


Services

Regulatory planning and guidance for development programs and submissions.

End-to-end program management from lead candidate selection through nonclinical safety and early clinical trials.

Monitoring of preclinical studies and auditing to ensure GLP compliance and data reliability.

Identify and engage qualified vendors across discovery to clinical phases and manage contracting relationships.

Pharmacology, (bio)analytical method support, immunology, toxicology advice and data analysis for development programs.

Access to a consultant matching platform to identify and engage regulatory, toxicology, CMC and clinical experts.

Expertise Areas

  • Clinical trial management
  • Regulatory strategy and submissions
  • Nonclinical toxicology
  • Bioanalytical method development
  • Show More (6)

Key Technologies

  • Bioanalytical assays
  • Nonclinical toxicology study design
  • GLP compliance monitoring
  • Clinical trial oversight
  • Show More (4)

News & Updates

Reported more than 140 development programs supported.

Reported over 85 sponsors engaged.

Reported more than two decades of combined experience supporting biotech development.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.